![Albert Hsia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Albert Hsia
Private Equity Investor bei iXLife Capital SAS
Aktive Positionen von Albert Hsia
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
iXLife Capital SAS
![]() iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Private Equity Investor | 01.01.2011 | - |
Karriereverlauf von Albert Hsia
Ehemalige bekannte Positionen von Albert Hsia
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Finnland | 2 |
Frankreich | 2 |
Operativ
Director/Board Member | 1 |
Private Equity Investor | 1 |
Sektoral
Commercial Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Commercial Services |
iXLife Capital SAS
![]() iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Finance |
- Börse
- Insiders
- Albert Hsia
- Erfahrung